Nurexone Biologic Quote - NRX

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.62

Bid

0.62

Offer

0.63

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

29.914M

Previous Close

0.62

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

48,249,000

Dividend Yield

PE Ratio

-8.22

Earnings Per Share (EPS)

-0.08

Revenue

Net Profit

-3.64M

Sector

Miscellaneous Metal Ores,nec

Industry

Pharmaceutical Preparations

Website

www.nurexone.com

Headquarters

Toronto, Ontario, Can

Founded

2011

Nurexone Biologic Inc is listed in the Miscellaneous Metal Ores sector of the TSX Venture Exchange with ticker NRX. The last closing price for Nurexone Biologic was $0.62. Over the last year, Nurexone Biologic shares have traded in a share price range of $ 0.00 to $ 0.00.

Nurexone Biologic currently has 48,249,000 shares in issue. The market capitalisation of Nurexone Biologic is $29.91 million. Nurexone Biologic has a price to earnings ratio (PE ratio) of -8.22.

NurExone Announces Promising Preclinical Results in Restoring Vision After Optic Nerve Damage

TORONTO and HAIFA, Israel, Dec. 06, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company...

NurExone Reports Third Quarter 2024 Financial Results and Provides Corporate Update

TORONTO and HAIFA, Israel, Nov. 27, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

NurExone Biologic Secures EMA Orphan Status for ExoPTEN in Spinal Cord Injury, Accelerating Pathway to European Markets

TORONTO and HAIFA, Israel, Nov. 13, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company...

NurExone Biologic Closes Final Tranche of Non-Brokered Private Placement and Provides Corporate Update

TORONTO and HAIFA, Israel, Nov. 01, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

NurExone’s Regenerative Medicine Therapies To Be Recognized at Fall Conferences in the USA

TORONTO and HAIFA, Israel, Oct. 23, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

NurExone Biologic Announces Private Placement of up to $2M and Closes First Tranche for $1.61M

TORONTO and HAIFA, Israel, Sept. 26, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

NurExone Biologic Extends Global Reach with Presentations at Industry-Leading Conferences

TORONTO and HAIFA, Israel, Sept. 12, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”), a biopharmaceutical company...

NurExone Demonstrates Extended Therapeutic Window of ExoPTEN Post Spinal-Cord Injury in Preclinical Study

TORONTO and HAIFA, Israel, Sept. 06, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”) is pleased to announce compelling...

NurExone Reports Second Quarter 2024 Financial Results and Provides Corporate Update

TORONTO and HAIFA, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical...

NurExone Biologic Invited to Present Groundbreaking ExoPTEN Therapy at Prestigious September Conferences

TORONTO and HAIFA, Israel, Aug. 23, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “Company” or “NurExone”) is pleased to announce that its...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

NRX - Frequently Asked Questions (FAQ)

What is the current Nurexone Biologic share price?

The current share price of Nurexone Biologic is $ 0.62

How many Nurexone Biologic shares are in issue?

Nurexone Biologic has 48,249,000 shares in issue

What is the market cap of Nurexone Biologic?

The market capitalisation of Nurexone Biologic is CAD 29.91M

What is the 1 year trading range for Nurexone Biologic share price?

Nurexone Biologic has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of Nurexone Biologic?

The price to earnings ratio of Nurexone Biologic is -8.22

What is the reporting currency for Nurexone Biologic?

Nurexone Biologic reports financial results in USD

What is the latest annual profit for Nurexone Biologic?

The latest annual profit of Nurexone Biologic is USD -3.64M

What is the registered address of Nurexone Biologic?

The registered address for Nurexone Biologic is SUITE 1600, 1 FIRST CANADIAN PLACE, 100 KING STREET, TORONTO, ONTARIO, M5X 1G5

What is the Nurexone Biologic website address?

The website address for Nurexone Biologic is www.nurexone.com

Which industry sector does Nurexone Biologic operate in?

Nurexone Biologic operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AAAAAuralite Investments Inc	$ 0.265 (0.00%)	0
AAA.PFirst Tidal Acquisition Corp	$ 0.04 (0.00%)	0
AAAlba Minerals Ltd	$ 0.03 (0.00%)	0
A.HArmor Minerals Inc	$ 0.31 (0.00%)	0
AArmor Minerals Inc	$ 0.45 (0.00%)	0
AAAAAuralite Investments Inc	$ 0.265 (0.00%)	0
AAA.PFirst Tidal Acquisition Corp	$ 0.04 (0.00%)	0
AAAlba Minerals Ltd	$ 0.03 (0.00%)	0
A.HArmor Minerals Inc	$ 0.31 (0.00%)	0
AArmor Minerals Inc	$ 0.45 (0.00%)	0
AAAAAuralite Investments Inc	$ 0.265 (0.00%)	0
AAA.PFirst Tidal Acquisition Corp	$ 0.04 (0.00%)	0
AAAlba Minerals Ltd	$ 0.03 (0.00%)	0
A.HArmor Minerals Inc	$ 0.31 (0.00%)	0
AArmor Minerals Inc	$ 0.45 (0.00%)	0